Navigation Links
Repair Stem Cell Institute Announces Science Advisory Board
Date:7/16/2008

utilization of RSC treatment of Type-2 diabetes and is the first and only known person with a successful clinical trial on helping Type-2 diabetes with repair stem cell treatment. He has treated hundreds of patients with RSC for heart disease, Type-2 diabetes and emphysema; both in his clinic in Argentina and in clinics in other Latin American countries. He is on the verge of another discovery for the most difficult to treat common disease of all, diabetes Type-1.

Professor Shimon Slavin, M.D., an expert bone marrow transplantation scientist and clinician, is world-famous for his innovative clinical application of cell-mediated immunotherapy for the treatment of hematological malignancies, solid tumors, immune disorders and a broad spectrum of non-malignant conditions treatable by stem cell transplantation. He and his team are the first known in the world to treat multiple sclerosis and amyotropic lateral sclerosis patients by injecting their spinal fluid with large numbers of repair stem cells (mesenchymal stromal stem cells) taken from their bone marrow and multiplied in culture. Dr. Slavin is the medical & scientific director of the newly established International Center for Cell Therapy & Cancer (ICTC) at the Tel Aviv (Sourasky) Medical Center in Israel.

Dr. Carlos Lima, M.D., one of the foremost neuropathologist experts in RSC treatments, rejected traditional bone marrow stem cells as a too limited source for the neurological stem cells required to repair injured spinal cords. Using olfactory stem cells harvested from the patients' own nose, Dr. Lima transplants the cells at the spinal cord break utilizing the successful OMA transplant surgical procedure he developed. Dr. Lima is the only doctor in the world whose treatments have created the neurological redevelopment required to allow some paraplegics to engage in extensive rehabilitation therapy, rise from their wheelchairs and walk.

Dr. Zannos G. Grekos, M.D., Director of Cardiology & V
'/>"/>

SOURCE The Repair Stem Cell Institute LLC
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related biology technology :

1. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
2. Small Bone Innovations Introduces New Distal Radius Plating System to Repair Complex Fractures
3. Cardica and Intuitive Surgical to Host Educational Symposium on Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair
4. Remergent(R) Announces the Launch of Four New Products Pioneers of DNA Repair Expand Anti-Aging Line
5. Boston Scientific Announces Sale of TriVascular Endovascular Aortic Repair Program
6. ES Vascular Receives CE Mark for its First Aortic Stapler for End-to-End Anastomosis Between Synthetic Grafts and Aorta During Open Repair of Aortic Aneurysmal and Occlusive Disease
7. CorMatrix(R) Announces FDA 510(k) for Novel Biomaterial Implant for Intracardiac Repair
8. Real-time observation of the DNA-repair mechanism
9. Worldwide Center for Adult Stem Cell Education LLC Changes Name to The Repair Stem Cell Institute LLC
10. Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology
11. Southern Research Institute Licenses Anti-Cancer Drug Compound to Virium Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 2013 Grace Century , an ... life science and health related private equity projects, has ... International Project Team. Dergham's expertise in finance and international ... to Grace Century as it continues to look at ... Dergham holds both an under graduate degree from the ...
(Date:5/20/2013)... ANGELES , May 20, 2013 Today, ... San Francisco , James McGough ... Clinical Psychiatry at the Semel Institute for Neuroscience and ... of Medicine at the University of California Los ... both Child and Adolescent Psychopharmacology and ADHD at UCLA, ...
(Date:5/20/2013)... 20, 2013 Pacific Biomarkers and Clinigene International are ... of biosimilars at the 2013 AAPS/ National Biotechnology ... Hotel and Marina , ... opportunity to speak with company representatives at their collaborative ... on May 21 from 1-2 p.m. in the conference,s ...
(Date:5/20/2013)... CHAPEL HILL, N.C. , May 20, 2013 ... pharmaceutical company focused on developing differentiated antibiotics to ... bacterial infections, today announced that it presented data ... 2013) in Philadelphia demonstrating ... versus levofloxacin in Cempra,s prior Phase 2 clinical ...
Breaking Biology Technology:Dalia Dergham Joins Grace Century FZ LLC International Project Team 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5Pacific Biomarkers and Clinigene International To Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference 2Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP) 2
... made clear this week -- with a one-two punch of ... -- that it intends to grow its GE Medical ... actually induce the Fairfield, Conn.-based giant to make additional acquisitions ... the product categories it just bought into, according to a ...
... conditions provide a golden opportunity to tune your talent ... to have calmed, the long-term winners will be those ... strategies. Real competitive advantage comes from making a ... aligning your talent management practice to that choice, even ...
... are still going on in the Midwest at places like the ... news story on Monday. There are many experts giving opinions about ... many jobs are going overseas for cheaper wages and most stop ... to stop because many companies are so focused on the bottom ...
Cached Biology Technology:GE Medicals Acquisitions May Prompt More Purchases 2GE Medicals Acquisitions May Prompt More Purchases 3Talent Constellations or Talent Communities Choosing the Right Talent 2Talent Constellations or Talent Communities Choosing the Right Talent 3Spend Money to Make Money and Dump Obsolete Tech Strategies 2Spend Money to Make Money and Dump Obsolete Tech Strategies 3Spend Money to Make Money and Dump Obsolete Tech Strategies 4
(Date:5/18/2013)... Research presented at Digestive Disease Week (DDW) ... diet and lifestyle. , Individuals suffering from ... strength, fatigue and poor quality of life. These ... remission. A randomized, double blind, placebo-controlled study found ... corresponded to significant relief of these symptoms. ...
(Date:5/17/2013)... The AGA Research Foundation announced a new grant that ... gut microbiota, one of today,s most exciting areas of ... AGA Research Awards Panel selected Andrew T. Chan, MD, ... Harvard Medical School, Boston, as the 2013 AGA-Elsevier Gut ... $25,000 of funding, commencing in July 2013, to test ...
(Date:5/17/2013)... Researchers at Rutgers, The State University of New Jersey, ... proprietary new formulation called Visikol TM that effectively ... be used in place of chloral hydrate, which is ... but which is tightly regulated by the Drug Enforcement ... , Clearing solutions, or clearing agents, are vital for ...
Breaking Biology News(10 mins):Research examines new methods for managing digestive health 2Research examines new methods for managing digestive health 3New gut microbiome research to explore red meat -- colorectal cancer pathway 2New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3
... unpleasant. Nearly 30% of all patients suffer from nausea ... are longer patient stays in the recovery room, with ... prevent postoperative nausea and vomiting. In a systematic review ... treatment recommendations for nausea after general anesthesia can be ...
... Spanish . A common roadside plant could ... biofuel, according to U.S. Department of Agriculture (USDA) studies. ... intramural scientific research agency, have found that field pennycress yields ... in biodiesel production. Field pennycress belongs to the ...
... the Arctic warms, a new cache of resourcessnow goose eggsmay ... In a new study published in an early online edition ... that even large numbers of hungry bears repeatedly raiding nests ... of the geese because of a mismatch in the timing ...
Cached Biology News:Pennycress could go from nuisance weed to new source of biofuel 2Polar bears can't eat geese into extinction 2
MOUSE ANTI RAT RT1Bu / MOUSE Ia:BIOTIN Immunogen: Rat thymocyte membrane glycoproteins...
Prepared in 0.85% saline....
... cloning of BAC (100+kb), fosmid (40kb), and ... stability than any othe BAC vector. On ... yields and easy recombinant DNA purification. Available ... (pSMART VC) vectors for the highest insert ...
Anti-Goat HRP-DAB Cell & Tissue Staining Kit...
Biology Products: